12-Month Lobbying Summary - Organization

Amgen Canada Inc. / Ugur Gunaydin, General Manager, Canada

Registration Summary

Currently active - Last Updated: 2025-09-03

Who is lobbying?

Amgen Canada Inc. (Address & business activities)

Ugur Gunaydin, General Manager, Canada

Government Funding

Did Amgen Canada Inc. receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

Amgen Canada Inc. is not working together with any other entity for the purpose of lobbying.

Direct Interests of the Lobbying Activity

Affiliates

Amgen Canada Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Amgen Inc. (Address information)

Other Affiliates

The activities of Amgen Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Amgen Canada Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Communicating with government officials, in general, about the pharmaceutical sector in British Columbia. The goal of these communications is (i) to keep the provincial government informed of general industry developments, initiatives and trends and (ii) to explore potential collaboration, in general, between industry and the provincial government.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
Communicating with government officials about improvements to approval processes for pharmaceuticals, including (i) streamlining rare disease drug review processes and (ii) harmonizing clinical trials and research ethics reviews.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about international trade, more specifically trade in the biopharmaceutical sector, including the impact of recent trade-related decisions by the United States of America on the biopharmaceutical sector in Canada.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, International Trade
Communicating with government officials about pharmaceutical drug coverage for Indigenous peoples.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Indigenous Relations and Reconciliation
Communicating with government officials about policies and programs designed to support innovative research and development in the pharmaceutical sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about the federal government's proposed national universal pharmacare program, including the bulk purchase of pharmaceuticals.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about the Government of British Columbia's "Life Sciences and Biomanufacturing Strategy".	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
Communicating with government officials about the Government of British Columbia's "Pharmaceutical Care Management Strategy".	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about the listing of Amgen's products for reimbursement purposes on government formularies, including on the BC PharmaCare Formulary.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health
Innovate BC
Jobs and Economic Growth
Member(s) of the BC Legislative Assembly
Post-Secondary Education and Future Skills
Providence Health Care Society
Provincial Health Services Authority
University of British Columbia

Ministries/Provincial Entities in previous versions
- Jobs, Economic Development and Innovation

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Angela Behboodi
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No